Torrent Pharmaceuticals Limited

NSEI:TORNTPHARM Stock Report

Market Cap: ₹1.1t

Torrent Pharmaceuticals (TORNTPHARM) Stock Overview

Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. More details

TORNTPHARM fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance5/6
Financial Health6/6
Dividends4/6

TORNTPHARM Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Torrent Pharmaceuticals Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Torrent Pharmaceuticals
Historical stock prices
Current Share Price₹3,314.20
52 Week High₹3,590.70
52 Week Low₹2,870.00
Beta0.18
1 Month Change3.38%
3 Month Change5.92%
1 Year Change12.40%
3 Year Change118.33%
5 Year Change176.91%
Change since IPO27,518.33%

Recent News & Updates

Pinning Down Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is Difficult Right Now

Jul 04
Pinning Down Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is Difficult Right Now

Recent updates

Pinning Down Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is Difficult Right Now

Jul 04
Pinning Down Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is Difficult Right Now

Should You Be Adding Torrent Pharmaceuticals (NSE:TORNTPHARM) To Your Watchlist Today?

Jun 13
Should You Be Adding Torrent Pharmaceuticals (NSE:TORNTPHARM) To Your Watchlist Today?

Torrent Pharmaceuticals' (NSE:TORNTPHARM) Dividend Will Be ₹6.00

May 23
Torrent Pharmaceuticals' (NSE:TORNTPHARM) Dividend Will Be ₹6.00

We Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt With Ease

Mar 12
We Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt With Ease

Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings

Feb 19
Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings

Torrent Pharmaceuticals Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Jan 28
Torrent Pharmaceuticals Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

If EPS Growth Is Important To You, Torrent Pharmaceuticals (NSE:TORNTPHARM) Presents An Opportunity

Dec 16
If EPS Growth Is Important To You, Torrent Pharmaceuticals (NSE:TORNTPHARM) Presents An Opportunity

Earnings Miss: Torrent Pharmaceuticals Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts

Oct 29
Earnings Miss: Torrent Pharmaceuticals Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts

Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Popularity With Investors Is Under Threat From Overpricing

Oct 24
Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Popularity With Investors Is Under Threat From Overpricing

Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Just Reported And Analysts Have Been Lifting Their Price Targets

Jul 26
Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Just Reported And Analysts Have Been Lifting Their Price Targets

Shareholder Returns

TORNTPHARMIN PharmaceuticalsIN Market
7D-1.6%-0.4%-0.08%
1Y12.4%8.4%-1.7%

Return vs Industry: TORNTPHARM exceeded the Indian Pharmaceuticals industry which returned 8.4% over the past year.

Return vs Market: TORNTPHARM exceeded the Indian Market which returned -1.7% over the past year.

Price Volatility

Is TORNTPHARM's price volatile compared to industry and market?
TORNTPHARM volatility
TORNTPHARM Average Weekly Movement3.1%
Pharmaceuticals Industry Average Movement5.6%
Market Average Movement5.8%
10% most volatile stocks in IN Market8.5%
10% least volatile stocks in IN Market3.9%

Stable Share Price: TORNTPHARM has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: TORNTPHARM's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
195917,059Samir Mehtawww.torrentpharma.com

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services.

Torrent Pharmaceuticals Limited Fundamentals Summary

How do Torrent Pharmaceuticals's earnings and revenue compare to its market cap?
TORNTPHARM fundamental statistics
Market cap₹1.13t
Earnings (TTM)₹19.11b
Revenue (TTM)₹115.16b
58.7x
P/E Ratio
9.7x
P/S Ratio

Is TORNTPHARM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TORNTPHARM income statement (TTM)
Revenue₹115.16b
Cost of Revenue₹27.76b
Gross Profit₹87.40b
Other Expenses₹68.29b
Earnings₹19.11b

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)56.47
Gross Margin75.90%
Net Profit Margin16.60%
Debt/Equity Ratio40.5%

How did TORNTPHARM perform over the long term?

See historical performance and comparison

Dividends

1.0%
Current Dividend Yield
57%
Payout Ratio

Does TORNTPHARM pay a reliable dividends?

See TORNTPHARM dividend history and benchmarks
When do you need to buy TORNTPHARM by to receive an upcoming dividend?
Torrent Pharmaceuticals dividend dates
Ex Dividend DateJun 20 2025
Dividend Pay DateJul 20 2025
Days until Ex dividend22 days
Days until Dividend pay date8 days

Does TORNTPHARM pay a reliable dividends?

See TORNTPHARM dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/11 11:33
End of Day Share Price 2025/07/11 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Torrent Pharmaceuticals Limited is covered by 59 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nitin BhasinAmbit Capital
Ashwin MehtaAmbit Capital
Prashant NairAmbit Capital